Re:Otonomo, with nearly $55M in funding, is cloning our product
by avip on Monday April 22, 2019 @04:21PM
(#19722537)
Addressing this case, for an Israeli company, infringing a US patent implies death. First, there's no "Israel market", US is the market. Second, there goes any chance of future funding. Last, a company s.a otonomo has one way out - acquisition. Say goodbye to that too.
Does it though? There is no global patent authority. If the ripoff is not for the US market, only a patent for their market will help. Which might be impossible to get in the first place.